Table 2.
Adverse drug reactions.
| FCL |
Non-FCL |
p-value* | |
|---|---|---|---|
| 139 cycles/49 pts | 163 cycles/60 pts | ||
| Grade 2, 3 non-haematologic toxicities: number of patients (%) | 29 (59) | 30 (50) | NS |
| Grade 2, 3 non-haematologic toxicities: number of events (%) | 67 (48) | 77 (47) | NS |
| Adverse events | |||
| Anorexia | 23 | 28 | |
| Nausea/vomiting | 8 | 13 | |
| Stomatitis | 7 | 6 | |
| Fatigue | 6 | 14 | |
| Diarrhoea | 6 | 3 | |
| Fever/FN | 5 | 2 | |
| Hand foot syndrome | 5 | 1 | |
| Skin rash | 4 | 0 | |
| Constipation | 3 | 10 | |
FCL: flowchart-type leaflet; cycles: number of chemotherapy cycles; pts: number of patients; FN: febrile neutropaenia.
*
χ2 test.